Also trades as: 092730.KS (KSC) · $vol 0M
092730.KQ KOE
NeoPharm Co. Ltd.
1W: -2.3%
1M: -4.9%
3M: +24.9%
YTD: +15.6%
1Y: +22.7%
3Y: +11.4%
5Y: -22.8%
₩23,100.00 ($17.20)
-200.00 (-0.86%)
Weekly Expected Move ±5.0%
₩20781
₩21940
₩23100
₩24260
₩25419
Overview
Chart
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
Smart Money Score
Watch
0
Insider—
Congress—
ETF Holdings—
Key Statistics
Market Cap₩361.3B ($269.0M)
52W Range15590-26000
Volume60,302
Avg Volume61,423
Beta0.17
Dividend₩600.00
Analyst Ratings
No analyst coverage
Company Info
CEOKim Yang-soo
Employees141
SectorConsumer Defensive
IndustryHousehold & Personal Products
IPO Date2007-01-30
Websiteneopharm.co.kr
309-8 Techno 2-ro
Daejeon, DE 34037
KR
Daejeon, DE 34037
KR
+82 42 863 5600
About NeoPharm Co. Ltd.
Established on July 1, 2000, NeoPharm Co., Ltd. is a Daejeon, South Korea-based company that develops, produces, and markets a diverse range of cosmetic, medical, and health products. Its offerings notably include advanced skincare formulations, both emulsified and functional, designed to address issues such as sensitive and dry skin, as well as to provide treatment for atopic dermatitis, psoriasis, and the adverse effects associated with steroid use.
Latest News
No recent news
Recent Insider Trades
No insider trades found